APP and Down syndrome: Importantly, we show that APP ASOs can reduce both intracellular and extracellular Aβ-containing aggregates in human neurons, indicating that this approach bears potential therapeutic significance in forms of AD caused by duplication of the APP gene, including monogenic AD and AD related to Down syndrome.